Bristol-Myers Squibb (BMY) Stories

Here is a selected set of our story library related to Bristol-Myers Squibb (BMY).

Bristol-Myers Squibb (BMY) - Dividend Analysis (Final Score: 5/8)

Comprehensive dividend analysis of Bristol-Myers Squibb (BMY) using an 8-criteria scoring system. Final score: 5/8, assessing dividend performance and stability.

Bristol-Myers Squibb (BMY) - Piotroski F-Score Analysis for Year 2023 (Final Score: 7/9)

Bristol-Myers Squibb (BMY) Piotroski F-Score 2023: Financial health at 7/9, reflecting strong profitability, liquidity, and asset efficiency.

If you accept cookies, we use them to improve and personalize your experience. Manage Cookies